Related Experiment Video
Updated: Jun 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular
A Dénise den Haan1, Boon Yew Tan, Michelle N Zikusoka
1Department of Medicine/Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Insights
Genetic analysis of 100 North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) found desmosome gene mutations in 52%. These mutations are linked to earlier onset and increased ventricular tachycardia risk in ARVD/C patients.
Area of Science:
- Cardiovascular Genetics
- Inherited Cardiac Diseases
- Molecular Cardiology
Background:
- Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited cardiac disorder.
- Mutations in cardiac desmosome genes are a common cause of ARVD/C.
- The prevalence of these mutations in North America was previously undescribed.
Purpose of the Study:
- To conduct comprehensive genetic analysis of desmosome components in North American patients with ARVD/C.
- To determine the prevalence and clinical significance of desmosome mutations in this population.
Main Methods:
- DNA sequencing of key desmosome genes (PKP2, DSG2, DSP, DSC2, JUP) was performed.
- Analysis included 100 individuals with clinically confirmed or suspected ARVD/C.
- Phenotypic data, including age of onset and ventricular tachycardia, were correlated with genetic findings.
Main Results:
- Desmosome mutations were identified in 52% of patients with ARVD/C, predominantly in the PKP2 gene.
- Individuals with desmosome mutations presented with earlier onset ARVD/C (33 vs. 41 years) and higher rates of ventricular tachycardia (73% vs. 44%).
- Mutations were found in 28% of suspected ARVD cases, with no significant phenotypic differences observed in this subgroup.
Conclusions:
- Over half of North American ARVD/C patients harbor identifiable mutations in cardiac desmosome genes.
- Desmosome gene mutations are associated with a more severe ARVD/C phenotype, including earlier onset and increased risk of ventricular tachycardia.
Background:
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited disorder typically caused by mutations in components of the cardiac desmosome. The prevalence and significance of desmosome mutations among patients with ARVD/C in North America have not been described previously. We report comprehensive desmosome genetic analysis for 100 North Americans with clinically confirmed or suspected ARVD/C.
Methods And Results:
In 82 individuals with ARVD/C and 18 people with suspected ARVD/C, DNA sequence analysis was performed on PKP2, DSG2, DSP, DSC2, and JUP. In those with ARVD/C, 52% harbored a desmosome mutation. A majority of these mutations occurred in PKP2. Notably, 3 of the individuals studied have a mutation in more than 1 gene. Patients with a desmosome mutation were more likely to have experienced ventricular tachycardia (73% versus 44%), and they presented at a younger age (33 versus 41 years) compared with those without a desmosome mutation. Men with ARVD/C were more likely than women to carry a desmosome mutation (63% versus 38%). A mutation was identified in 5 of 18 patients (28%) with suspected ARVD. In this smaller subgroup, there were no significant phenotypic differences identified between individuals with a desmosome mutation compared with those without a mutation.
Conclusions:
Our study shows that in 52% of North Americans with ARVD/C a mutation in one of the cardiac desmosome genes can be identified. Compared with those without a desmosome gene mutation, individuals with a desmosome gene mutation had earlier-onset ARVD/C and were more likely to have ventricular tachycardia.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Desmosomes
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias

